Illumina expands Billion Cell Atlas program with new AI drug developers

{
  "signal_id": "10ad04e5-3382-bb0a-1f8e-18a2de23f605",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-07-16T16:00:00+00:00",
  "company": {
    "name": "Illumina",
    "domain": "illumina.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/illumina-expands-billion-cell-atlas-program-with-new-ai-drug-developers-302827780.html",
    "title": "Illumina expands Billion Cell Atlas program with new AI drug developers",
    "excerpt": "Partners will use unprecedented data scale to advance more precise medicines to approval SAN DIEGO , July 16, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN ) today announced that the Billion Cell Atlas alliance has added three new member companies, including AI-native drug developer Formation Bio. As leaders in AI-driven drug discovery, design, and development, alliance members will use the unprecedented scale of Illumina's genome-wide perturbation data as infrastructure for the next generation of therapeutics. \"We are building the cell atlas to address key bottlenecks across the drug discovery and development continuum,\" said Rami Mehio, senior vice president and general manager of BioInsight at Illumina. \"We are creating the foundational framework to train virtual cell models and solve some of the most fundamental challenges in biology. Together, partners using this unique dataset can have a significant impact in de-risking and accelerating the journey from biological insights to approved drugs.\" Introduced in January 2026 with founding participants AstraZeneca, Merck, and Eli Lilly and Company, the Atlas enables users to discover and validate novel targets, characterize drug and disease mechanisms of action, and explore potential new indications. Over 350 million cells have been sequenced to date, generating upwards of six petabytes of genomic data. The scale and...",
    "product": "Billion Cell Atlas",
    "summary": "Illumina's Billion Cell Atlas alliance has added AI-native drug developer Formation Bio as a new member.",
    "location": "San Diego, California, USA",
    "planning": false,
    "image_url": "https://mmx.prnewswire.com/media/MS1884373/Illumina-BillionCellAtlas.mp4?id=OA2767749&p=thumbnail",
    "confidence": 0.9,
    "product_data": {
      "name": "Billion Cell Atlas",
      "full_text": "Billion Cell Atlas program",
      "fuzzy_match": false
    },
    "product_tags": [
      "data",
      "medical",
      "future_tech"
    ],
    "published_at": "2026-07-16T16:00:00Z",
    "location_data": [
      {
        "city": "San Diego",
        "state": "California",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-07-16",
    "article_sentence": "Illumina, Inc. (NASDAQ: ILMN ) today announced that the Billion Cell Atlas alliance has added three new member companies, including AI-native drug developer Formation Bio.",
    "related_company_name": "Formation Bio",
    "related_company_domain": "formation.bio"
  }
}

curl https://signals.autobound.ai/v1/signals/10ad04e5-3382-bb0a-1f8e-18a2de23f605 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"illumina.com","limit":20}'